XNW27011

· Evopoint Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XNW27011, covering 2025-02-07 to 2025-02-07. Get the full timeline:

Most recent: Clinical Trial Update: XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. [Phase 1, Phase 2]